Review
Oct 2026
[LDL-c and residual cardiovascular risk in patients with coronary artery disease].
Although the expanding therapeutic armamentarium allows for increased substantial LDL-c reductions, this has not translated into a corresponding improvement in target attainment and the underlying reasons are complex and multifactorial.
Thomas de Saint Nicolas, Hubert Dromas, Gilles Lemesle
· Annales de cardiologie et d'... · 0 citations